Merzee
Product Images NDC 43386-371

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Merzee (NDC 43386-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1

Figure 1
Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives are listed with their titles, authors, and years. The studies compare the risk of breast cancer between ever COC (Combined Oral Contraceptives) use and never COC use, and between current COC use and never-use. The risk ratios and confidence intervals for each study are also provided.*
FDA Label Image

Figure 2

FDA Label Image

Figure 3

FDA Label Image

Figure 4

Figure 4
This text seems to be discussing different methods of birth control with a focus on preventing pregnancies. It states that there are fewer than 1 pregnancy per 100 pregnancies per 100 women, and that there are more pregnancies when using certain methods. It then lists various birth control options such as implants, injections, intrauterine devices, sterilization, skin patches, vaginal hormones, condoms, diaphragms, and various natural methods.*
FDA Label Image

Figure 5

FDA Label Image

Merzee Carton Label (Merzee Carton)

Merzee Carton Label (Merzee Carton)
This text is for a medication called "Merzee" that is available only through prescription. It comes in capsule form with a dosage of 1mg/20mg and contains a combination of roreindone aceta, iy esaciol caguies, and ferrous fumarate. It provides 21 or 24 days of active therapy depending on the type of capsule prescribed. The medication is intended to prevent pregnancy and also has other benefits relating to hormone regulation.*
FDA Label Image

Structure-1 (Structure1)

FDA Label Image

Structure-2 (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.